Department of Otorhinolaryngology, Head and Neck Surgery, China-Japan Union Hospital of Jilin University, Changchun, China.
Am J Rhinol Allergy. 2011 Mar-Apr;25(2):116-9. doi: 10.2500/ajra.2011.25.3572. Epub 2011 Jan 28.
Skin-prick testing (SPT) is the most common screening method for allergy evaluation. The detection of serum-specific immunoglobulin E (sIgE) is also commonly used. The sensitivity and specificity of these testing methods may vary due to type of causative allergen and type of allergic manifestation. The purpose of this study was to evaluate the correlation between two methods of measuring sIgE (AllergyScreen [Mediwiss Analytic GmbH, Moers, Germany] and ImmunoCAP [Pharmacia, Uppsala, Sweden]) and SPT for the diagnosis of allergic rhinitis (AR).
All 216 patients who were referred to the allergist for suspected AR from June to October 2009 had SPT and the two serological tests. One hundred fifty-eight patients had a positive clinical history and a related positive SPT. The SPT was used as reference standard, and we selected three allergens (Dermatophagoides pteronyssinus, mugwort, and ragweed), which were common in fall in northeast China, to analyze the correlation of the two serum tests and SPT.
Compared with the SPT, the diagnostic indexes (accuracy, sensitivity and specificity) of the AllergyScreen system and the ImmunoCAP system were 0.819 versus 0.810, 0.780 versus 0.872, and 0.862 versus 0.741, respectively. The accuracy was similar between the two systems (p > 0.05). The ImmunoCAP system method had a higher sensitivity (p < 0.01). The AllergyScreen system had a higher specificity (p < 0.01).
These data support that the AllergyScreen system and ImmunoCAP system can identify potentially significant allergens in the diagnosis of AR in patients from northeastern China.
皮肤点刺试验(SPT)是评估过敏最常用的筛查方法。血清特异性免疫球蛋白 E(sIgE)检测也常用。由于致病过敏原和过敏表现类型的不同,这些检测方法的敏感性和特异性可能会有所不同。本研究旨在评估两种 sIgE 测量方法(AllergyScreen[Mediwiss Analytic GmbH,Moers,Germany]和 ImmunoCAP[Pharmacia,Uppsala,Sweden])与 SPT 对过敏性鼻炎(AR)诊断的相关性。
2009 年 6 月至 10 月,所有因疑似 AR 而被转介至过敏专家的 216 例患者均进行了 SPT 和两种血清学检测。158 例患者有阳性临床病史和相关阳性 SPT。以 SPT 为参考标准,我们选择了三种在东北地区秋季常见的过敏原(屋尘螨、蒿属和豚草),分析了两种血清检测和 SPT 的相关性。
与 SPT 相比,AllergyScreen 系统和 ImmunoCAP 系统的诊断指标(准确性、敏感性和特异性)分别为 0.819 对 0.810、0.780 对 0.872 和 0.862 对 0.741。两种系统的准确性相似(p>0.05)。ImmunoCAP 系统方法的敏感性更高(p<0.01)。AllergyScreen 系统的特异性更高(p<0.01)。
这些数据支持 AllergyScreen 系统和 ImmunoCAP 系统可用于识别中国东北地区患者 AR 潜在的重要过敏原。